Mark Auerbach

Mark Auerbach

Plus aucun poste en cours
87 ans
Health Technology
Consumer Services
Industrial Services

Profil

Mark Auerbach served as Chairman, President, Chief Executive Officer & CFO at Sterling Infrastructure, Inc. from 1995 to 1997.
He was also Executive Chairman at Endo Generics Holdings, Inc. and Non-Executive Chairman at Par Pharmaceutical, Inc. in 2006.
From 2006 to 2010, he served as Chairman at Woodbrook Group Holdings, Inc. He was a Director at RxElite, Inc., Ventrus Biosciences, Inc., RxElite Holdings, Inc., and Collexis Holdings, Inc. He also served as Lead Independent Director at Optimer Pharmaceuticals LLC from 2005 to 2013.
Since 2010, he has been an Independent Director at Assembly Biosciences, Inc. and is currently an Independent Director at Pardes Biosciences, Inc. He was previously the Chief Financial Officer & Senior Vice President at Central Lewmar LP from 1993 to 2005.
He also worked as a Partner at Masco Associates, Inc. Mr. Auerbach received his undergraduate degree from Rider University.

Anciens postes connus de Mark Auerbach

SociétésPosteFin
PARDES BIOSCIENCES, INC. Président 01/03/2022
ASSEMBLY BIOSCIENCES, INC. Directeur/Membre du Conseil 11/06/2020
RCS CAPITAL CORP Président 01/06/2016
Directeur/Membre du Conseil 24/10/2013
WOODBROOK GROUP HOLDINGS INC. Président 31/03/2010
Voir l'expérience en détail de Mark Auerbach

Formation de Mark Auerbach

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

55

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées15

Industrial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Distribution Services

Finance

Health Technology

Technology Services

Masco Associates, Inc.

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Mark Auerbach
🔇